https://www.indianpharmapost.com/astrazeneca-pharma-india-posts-30-growth-in-q2-revenue-hits-rs-7291-cr-223432026-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicare-q2-fy27-pat-soars-80-to-rs-792-crore-on-strong-api-growth-223442026-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-receives-brazil-approval-for-generic-semaglutide-injection-223452026-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/supriya-lifescience-q2-fy27-pat-drops-42-to-rs-292-cr-223462026-11-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/marksans-pharma-q2-fy27-pat-surges-448-to-rs-1435-cr-223472026-11-07T00:00:00+05:30always0.9